1. Home
  2. PLSE vs AMPH Comparison

PLSE vs AMPH Comparison

Compare PLSE & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • AMPH
  • Stock Information
  • Founded
  • PLSE 2014
  • AMPH 1996
  • Country
  • PLSE United States
  • AMPH United States
  • Employees
  • PLSE N/A
  • AMPH N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLSE Health Care
  • AMPH Health Care
  • Exchange
  • PLSE Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • PLSE 1.2B
  • AMPH 1.2B
  • IPO Year
  • PLSE 2016
  • AMPH 2014
  • Fundamental
  • Price
  • PLSE $16.15
  • AMPH $25.32
  • Analyst Decision
  • PLSE Buy
  • AMPH Buy
  • Analyst Count
  • PLSE 1
  • AMPH 6
  • Target Price
  • PLSE $22.00
  • AMPH $35.50
  • AVG Volume (30 Days)
  • PLSE 133.2K
  • AMPH 368.5K
  • Earning Date
  • PLSE 11-05-2025
  • AMPH 11-06-2025
  • Dividend Yield
  • PLSE N/A
  • AMPH N/A
  • EPS Growth
  • PLSE N/A
  • AMPH N/A
  • EPS
  • PLSE N/A
  • AMPH 2.68
  • Revenue
  • PLSE N/A
  • AMPH $722,679,000.00
  • Revenue This Year
  • PLSE N/A
  • AMPH $0.74
  • Revenue Next Year
  • PLSE $700.00
  • AMPH $5.63
  • P/E Ratio
  • PLSE N/A
  • AMPH $9.44
  • Revenue Growth
  • PLSE N/A
  • AMPH 1.37
  • 52 Week Low
  • PLSE $13.77
  • AMPH $20.39
  • 52 Week High
  • PLSE $25.00
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 37.34
  • AMPH 52.59
  • Support Level
  • PLSE $17.10
  • AMPH $23.77
  • Resistance Level
  • PLSE $18.35
  • AMPH $25.85
  • Average True Range (ATR)
  • PLSE 0.64
  • AMPH 0.71
  • MACD
  • PLSE -0.20
  • AMPH 0.28
  • Stochastic Oscillator
  • PLSE 3.66
  • AMPH 82.70

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: